Open access · CC-BY
via OpenAlex
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk
Stéphane Laurent, Gilles Châtellier, Michel Azizi, David Calvet, Gabriel J. Choukroun, Nicolas Danchin, Pascal Delsart, Xavier J. Girerd, Philippe Gosse, Hakim Khettab, Gerard Michel London, Jean‐Jacques Mourad, Bruno Pannier, Héléna Pereira, Dominique Stéphan
Hypertension · 2021 · ▲ 118 citations
Abstract
The SPARTE study (Strategy for Preventing cardiovascular and renal events based on ARTErial stiffness; URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02617238) is a multicenter open-label randomized controlled trial with blinded end point evaluation, undertaken at 25 French research centers in university hospitals. Patients with primary hypertension were randomly assigned (1:1) to a therapeutic strategy targeting the normalization of carotid-femoral pulse wave velocity (PWV) measured every 6 months (PWV group, n=264) versus a classical therapeutic strategy only implementing the European Guidelines for Hypertension Treatment (conventional group, n=272). In the PWV group, the therapeutic strategy used preferably a combination of ACE (angiotensin-converting enzyme) inhibitor or angiotensin receptor blocker and calcium channel blockers, as well as maximal recommended doses of ACE inhibitors and angiotensin receptor blockers. The primary outcome was a combined end point including particularly stroke and coronary events. Secondary outcomes included the time-course changes in brachial office blood pressure (BP), ambulatory BP, PWV, and treatments. After a median follow-up of 48.3 months, there was no significant between-group difference in primary outcome (hazard ratio, 0.74 [95% CI, 0.40–1.38], P =0.35). In the PWV group, combinations of renin-angiotensin-system blockers and calcium channel blockers were prescribed at higher dosage ( P =0.028), office and ambulatory systolic blood pressure and diastolic blood pressure decreased more ( P <0.001 and P <0.01, respectively), and PWV increased less ( P =0.0003) than in the conventional group. The SPARTE study lacked sufficient statistical power to demonstrate its primary outcome. However, it demonstrated that a PWV-driven treatment for hypertension enables to further reduce office and ambulatory systolic blood pressure and diastolic blood pressure and prevent vascular aging in patients with hypertension at medium-to-very-high risk, compared with strict application of guidelines.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1161/hypertensionaha.121.17579
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Laurent, S., Châtellier, G., Azizi, M., Calvet, D., Choukroun, G.J., Danchin, N., Delsart, P., Girerd, X.J., Gosse, P., Khettab, H., London, G.M., Mourad, J., Pannier, B., Pereira, H., Stéphan, D., Valensi, P.E., Cunha, P., Narkiewicz, K., Bruno, R.M., & Boutouyrie, P. (2021). SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk. <em>Hypertension</em>. https://doi.org/10.1161/hypertensionaha.121.17579
Vancouver
Laurent S, Châtellier G, Azizi M, Calvet D, Choukroun GJ, Danchin N, et al. SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk. Hypertension. 2021. doi:10.1161/hypertensionaha.121.17579.
BibTeX
@article{stphane2021SPARTE,
title = {SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk},
author = {Stéphane Laurent and Gilles Châtellier and Michel Azizi and David Calvet and Gabriel J. Choukroun and Nicolas Danchin and Pascal Delsart and Xavier J. Girerd and Philippe Gosse and Hakim Khettab and Gerard Michel London and Jean‐Jacques Mourad and Bruno Pannier and Héléna Pereira and Dominique Stéphan and Paul Elie Valensi and Pedro Cunha and Krzysztof Narkiewicz and Rosa María Bruno and Pierre Boutouyrie and on behalf of SPARTE Investigators},
journal = {Hypertension},
year = {2021},
doi = {10.1161/hypertensionaha.121.17579},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
JACC. Advances 2026
Open access · OA
Arterial Stiffness Mechanisms and Orthostatic Hypotension in SPRINT: A Randomized Controlled Trial.
Clinical Hypertension 2023
Open access · CC-BY
Arterial stiffness and hypertension
BMC Cardiovascular Disorders 2021
Open access · CC-BY
The relationship between ambulatory arterial stiffness, inflammation, blood pressure dipping and cardiovascular outcomes
International Journal of Cardiovascular Sciences 2020
Open access · CC-BY
Vascular Aging and Arterial Stiffness in Older Adults
Hypertension 2006
Open access · OA
Increased Ambulatory Arterial Stiffness Index Is Associated With Target Organ Damage in Primary Hypertension
Blood Pressure Monitoring 2006
Preprint · OA